Insider trading · Q3 2026 · CIK 1401914

Dare Bioscience, Inc. (DARE) insider trading.

In Q3 2026, insiders at Dare Bioscience, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
5
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
5
Last filed
2026-07-02

Insiders

InsiderRelationshipTransactionsBuysSales
Steele Robin JoanDirector100
Rastetter William HDirector100
Matz Gregory WDirector100
Kelley Susan L.Director100
Grossman Jessica D.Director100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-06-30Steele Robin JoanA (A)26,540$047,055Form 4
2026-06-30Rastetter William HA (A)38,862$039,721Form 4
2026-06-30Matz Gregory WA (A)30,805$030,847Form 4
2026-06-30Kelley Susan L.A (A)23,696$023,696Form 4
2026-06-30Grossman Jessica D.A (A)26,066$026,066Form 4

Transaction codes in this quarter

Get DARE insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1401914&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · DARE company page · Dare Bioscience, Inc. on SEC.gov

Questions

Are insiders buying or selling Dare Bioscience, Inc. (DARE)?

In Q3 2026, insiders at Dare Bioscience, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Dare Bioscience, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/dare.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.